Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecologic Cancer Intergroup Symptom Benefit Study

Open access

Abstract

Learning Objectives: Explain the connection between depression and unrealistic expectations of the benefits of palliative therapy. Distinguish the trait of general hopefulness from hope for a specific favorable outcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1634/theoncologist.2013-0175

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

See all 43

Metadata

Authors
Sjoquist, K. M., Friedlander, M. L., O'Connell, R. L., Voysey, M., King, M. T., Stockler, M. R., Oza, A. M., Gillies, K., Martyn, J. K., & Butow, P. N.
Affiliations
  • The University of Sydney (AU)
  • Australian and New Zealand Gynaecological Oncology Group and National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia;
  • Princess Margaret Cancer Centre (CA)
Corresponding author
Butow, Phyllis N.
Venue
The Oncologist
Published
2013-10-09
Volume
18
Issue
11
Pages
1221-1228
ISSN
  • 1083-7159 (ISSN-L)
  • 1549-490X
OpenAlex
W2103017000
Cited by
43
References
46
Citations by year
2026: 2 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 4 · 2015: 6 · 2014: 2
FWCI
4.11
Type
journal article
Language
en
Open access
Locations
  • The Oncologist (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
Funders
  • Australian National Health and Medical Research Council (APP570893)
  • Ovarian Cancer Research Foundation
Topics
  • Social Sciences › Psychology › Applied Psychology › Optimism, Hope, and Well-being
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
Keywords
trait hope, platinum-resistant ovarian cancer, recurrent ovarian cancer, chemotherapy, perceived treatment effectiveness, depression, anxiety, quality of life, patient expectations
MeSH terms
Carcinoma, Ovarian Epithelial, Adult, Aged, Aged, 80 and over, Anxiety, Depression, Female, Humans, Longitudinal Studies, Middle Aged, Neoplasm Recurrence, Local, Neoplasms, Glandular and Epithelial, Organoplatinum Compounds, Ovarian Neoplasms, Prognosis, Quality of Life, Surveys and Questionnaires, Treatment Outcome, Drug Resistance, Neoplasm, Hope

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecologic Cancer Intergroup Symptom Benefit Study. https://app.cochat.ai/papers/10.1634/theoncologist.2013-0175
The paper
Sjoquist, K. M., Friedlander, M. L., O'Connell, R. L., Voysey, M., King, M. T., Stockler, M. R., Oza, A. M., Gillies, K., Martyn, J. K., & Butow, P. N. (2013). Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecologic Cancer Intergroup Symptom Benefit Study. The Oncologist. https://doi.org/10.1634/theoncologist.2013-0175

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.